Tissue plasminogen activator for acute ischemic stroke
[No authors listed] The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
[No authors listed] (1995) Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group N Engl J Med 333: 1581-1587
Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study
Albers GW et al. (2006) Magnetic resonance imaging profiles predict clinical response to early reperfusion: The diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol 60: 508-517
Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study
IMS Study Investigators
IMS Study Investigators (2004) Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke 35: 904-911
AstraZeneca International (online 26 October) AstraZeneca announces SAINT II trial results showed no efficacy in acute ischaemic stroke (accessed 30th October 2006)
AstraZeneca International (online 26 October 2006) AstraZeneca announces SAINT II trial results showed no efficacy in acute ischaemic stroke [http://www.astrazeneca.com/pressrelease/5279.aspx] (accessed 30th October 2006)
(2006)
9
0242501513
Comparison of the neuroprotective effect of clomethiazole, ARR15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures
Marshall JW et al. (2003) Comparison of the neuroprotective effect of clomethiazole, ARR15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Res 972: 119-126